Charles Schwab Investment Management Inc Moderna, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,967,589 shares of MRNA stock, worth $234 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,967,589

Previous 1,871,399 5.14%

Holding current value

$234 Million

Previous $186 Million 12.66%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$85.37 - $115.44 $8.21 Million - $11.1 Million	96,190 Added 5.14%	1,967,589 $210 Million
Q4 2023 Feb 06, 2024	BUY	$69.51 - $104.43 $4.89 Million - $7.35 Million	70,368 Added 3.91%	1,871,399 $186 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $4.71 Million - $6.19 Million	48,851 Added 2.79%	1,801,031 $186 Million
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $4.76 Million - $6.44 Million	-40,127 Reduced 2.24%	1,752,180 $213 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $4.59 Million - $6.67 Million	33,844 Added 1.92%	1,792,307 $275 Million

Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $1.04 Million - $1.85 Million	8,824 Added 0.5%	1,758,463 $316 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $13.5 Million - $22.2 Million	114,077 Added 6.97%	1,749,639 $207 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $1.41 Million - $2.12 Million	12,025 Added 0.74%	1,635,562 $234 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $6.33 Million - $11.8 Million	50,051 Added 3.18%	1,623,537 $280 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $8.05 Million - $13.1 Million	35,670 Added 2.32%	1,573,486 $400 Million
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $162 Million - $354 Million	730,049 Added 90.38%	1,537,816 $592 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $3.46 Million - $6.26 Million	26,621 Added 3.41%	807,767 $190 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $5.04 Million - $8.59 Million	46,203 Added 6.29%	781,146 $102 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $1.21 Million - $3.13 Million	18,423 Added 2.57%	734,943 $76.8 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $40.2 Million - $70.1 Million	-739,495 Reduced 50.79%	716,520 $50.7 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $13 Million - $35.1 Million	438,140 Added 43.04%	1,456,015 $93.5 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $3.13 Million - $5.56 Million	176,099 Added 20.92%	1,017,875 $30.5 Million
Q4 2019 Feb 07, 2020	BUY	$13.93 - $21.28 $316,238 - $483,098	22,702 Added 2.77%	841,776 $16.5 Million
Q3 2019 Nov 08, 2019	BUY	$12.26 - $18.07 $10 Million - $14.8 Million	819,074 New	819,074 $13 Million

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Moderna, Inc. Transaction History